EricBleickardtMD

Hematologic Oncology

Physician

Dr. Bleickardt is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 1999 - 2002
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1996 - 1999
Rutgers Robert Wood Johnson Medical SchoolClass of 1996

PubMed

18 citations
Paediatric Strategy Forum for medicinal product development of chimeric antigen receptor T-cells in children and adolescents with cancer: ACCELERATE in collaboration w...
Andrew D.J. Pearson, Claudia Rossig, Crystal L. Mackall, Nirali N. Shah, André Baruchel
European Journal of Cancer. 2021-11-25
247 citations
Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma.
Marcelo C. Pasquini, Zhen-Huan Hu, Kevin J. Curran, Theodore W. Laetsch, Frederick L. Locke
Blood Advances. 2020-11-10
9 citations
Industry's Giant Leap Into Cellular Therapy: Catalyzing Chimeric Antigen Receptor T Cell (CAR-T) Immunotherapy.
Stacie Ittershagen, Solveig G. Ericson, Lamis K. Eldjerou, Ali Shojaee, Eric Bleickardt
Current Hematologic Malignancy Reports. 2019-02-01

Abstracts/Posters

Tisagenlecleucel Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Children and Young Adults with Acute Lymphoblastic Leukemia (ALL): Real World E...
Eric Bleickardt, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Tisagenlecleucel Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Children and Young Adults with Acute Lymphoblastic Leukemia (ALL): Real World E...
Eric Bleickardt, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

Molecular Detection of Minimal Residual Disease Precedes Morphological Relapse and Could be Used to Identify Relapse in Pediatric and Young Adult B-Cell Acute Lymphobl...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

LinkedInhttps://www.linkedin.com/in/eric-bleickardt-3067305?trk=contact-info